维普中文期刊产品整合服务
14篇 您的检索式:作者名="Robertson LE"
    题名 作者 年代 出处 被引量
1Implications of apoptotic cell death regulation in cancer therapy 显示文摘McDonnel LTJ Meyn RE Robertson LE 1995Semin Cancer Biol1995,6,1:1
2Bcl-2 epression in choronic lymphocytic loukemia and its correlation with the induction if apoptosis and clinical outcome显示文摘Robertson LE Plunkett W Me Connell K 1996Leukemia1996,10,:1
3Alterations in leucocyte teta - receptor affinity with ageing 显示文摘Feldman RD Limbird LE Nadeau J Robertson D Wood AJJ 1984N Engl J Med1984,310,:1
4Response to suxamethonium during propofol-fentanyl-N2O/O2 anaesthesia in a patient with active myasthenia gravis recieving longterm anticholinesterase therapy显示文摘Vanlinthout LE Robertson EN Booi JLH 1994Anaesthesia1994,49,:1
5Implications of apoptotic cell death regulation in cancer therapy显示文摘McDonnell TJ Meyn RE Robertson LE 1995Semin Cancer Biol1995,6,1:1
6Ensuring a knowledgeable and committed gerontological nursing work- force 显示文摘Plonczynski D J Jones LE Robertson JF 2007Nurse Education Today2007,27,2:1
7Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2I -deoxyadenosine and 9-beta-D-arabinosyl- 2 显示文摘Robertson LE Chubb S Meyn RE 1993Blood1993,81,1:1
8Richter's syndrome:a report on 39 patients显示文摘Robertson LE Pugh W O' Brien S 1993J Clin Oncol1993,11,10:1
9Bacillus spore inactivation differences after combined mild temperature and gigh pressure processing using two pressurizing fluids显示文摘Robertson RE Carroll T Pearee LE 2008J Food Prot2008,71,6:1
10Induction of Apoptotic cell Death in chronic lymphocytic leukemia by 2-2'-deoxydenosiue and 9-B-D-Arabinosy 1-2-fluoademine 显示文摘By LE Robertson Sherr Chubb Raymond E 1993Blood1993,81,:1
11Human ureaplasmas show diverse genome sizes by pulse-field eleetrophoresis 显示文摘Robertson J A Pyle LE Stemke G W 1990Nucleic Acids Res1990,18,6:1
12Richter's syndrome : a report on 39 patients显示文摘Robertson LE Pugh W O'Brien S 1993J Clin Oncol1993,11,:1
13Implications of apoptotic cell death regulation in cancer therapy 显示文摘Mc Donnell TJ Meyn RE Robertson LE 1995Semin Cancer Biol1995,6,1:1
14Survival outcomes and predictors of mortality,re-bleeding and complications for acute severe variceal bleeding requiring balloon tamponade显示文摘BACKGROUND Acute severe variceal bleeding(AVB)refractory to medical and endoscopic therapy is infrequent but associated with high mortality.Historical cohort studies from 1970-1980s no longer represent the current population as balloon tamponade is no longer first-line therapy for variceal bleeding;treatments including vasoactive therapies,intravenous antibiotics,endoscopic variceal band ligation are routinely used,and there is improved access to definitive treatments including transjugular intrahepatic portosystemic shunts.However,only a few studies from the current era exist to describe the practice of balloon tamponade,its outcomes,and predictors with a requirement for further updated information.AIM To describe current management of AVB requiring balloon tamponade and identify the outcomes and predictors of mortality,re-bleeding and complications.METHODS A retrospective multi-centre cohort study of 80 adult patients across two large tertiary health networks from 2008 to 2019 in Australia who underwent balloon tamponade using a Sengstaken-Blakemore tube(SBT)were included for analysis.Patients were identified using coding for balloon tamponade.The primary outcome of this study was all-cause mortality at 6 wk after the index AVB.Secondary outcomes included re-bleeding during hospitalisation and complications of balloon tamponade.Predictors of these outcomes were determined using univariate and multivariate binomial regression.RESULTS The all-cause mortality rates during admission and at 6-,26-and 52 wk were 48.8%,51.2%and 53.8%,respectively.Primary haemostasis was achieved in 91.3%and re-bleeding during hospitalisation occurred in 34.2%.Independent predictors of 6 wk mortality on multivariate analysis included the Model for Endstage Liver disease(MELD)score(OR 1.21,95%CI 1.06-1.41,P=0.006),advanced hepatocellular carcinoma(OR 11.51,95%CI 1.61-82.20,P=0.015)and re-bleeding(OR 13.06,95%CI 3.06-55.71,P<0.001).There were no relevant predictors of re-bleeding but a large proportion in which this occurred did not survive 6 wk(76.0%vs 24%).Although mucosal trauma was the most common documented complication after SBT insertion(89.5%),serious complications from SBT insertion were uncommon(6.3%)and included 1 patient who died from oesophageal perforation.CONCLUSION In refractory AVB,balloon tamponade salvage therapy is associated with high rates of primary haemostasis with low rates of serious complications.Re-bleeding and mortality however,remain high.Charlotte Y Keung Aparna Morgan Suong T Le Marcus Robertson Paul Urquhart Michael P Swan 2022World Journal of Hepatology2022,14,8:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费